UT Southwestern O'Brien Kidney Research Core Center
德州大学西南奥布莱恩肾脏研究核心中心
基本信息
- 批准号:8148016
- 负责人:
- 金额:$ 1.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-08-03 至 2012-05-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAnimal ModelAreaBasic ScienceBiomedical ResearchCardiovascular DiseasesCellular biologyChronic Kidney FailureClinicalClinical InvestigatorClinical SciencesCollaborationsCongenital AbnormalityCore FacilityCystic Kidney DiseasesDevelopmentDevelopmental BiologyDiseaseFunctional disorderFundingGoalsGrantHumanHuman GeneticsInflammationInjuryInternal MedicineKidneyKidney DiseasesMedical centerMinerals/Electrolytes MetabolismMolecular GeneticsNephrologyPathogenesisPathologyPatientsPediatricsPhysiciansPhysiologyResearchResearch PersonnelScientistTechnologyTexasTrainingTransgenic OrganismsTranslatingTranslational ResearchUniversitiesbaseeffective therapyinsightinterdisciplinary approachmolecular pathologynephrogenesisprofessorprogramssquare footsymposium
项目摘要
DESCRIPTION, OVERALL (provided by applicant):
This is a new application for the establishment of a George M. O'Brien Kidney Research Core Center at the University of Texas Southwestern Medical Center at Dallas. The Director is Dr. Peter Igarashi, Professor of Internal Medicine and Pediatrics, and Chief of the Division of Nephrology. The overall goal of the Center is to promote bidirectional interactions between basic scientists and clinical researchers that will enhance our understanding of kidney development and pathophysiology and result in more effective treatments of kidney diseases and their complications. This goal will be achieved through the creation of new animal models of kidney diseases and the development of core facilities that will enable physician-scientists who are conducting basic research to more easily translate their findings to humans. Conversely, clinical investigators who are studying patients with renal diseases will identify molecular and genetic abnormalities that can then be studied to derive new insights into disease pathogenesis and treatment. To achieve these goals, the Center will support five Biomedical Research Cores, a Pilot & Feasibility Program, and an Educational Enrichment Program. The Biomedical Research Cores are: 1) Animal Models, 2) Physiology, 3) Cell Biology & Pathology, 4) Molecular Genetics, and 5) Clinical/Translational. The Cores will support ongoing, kidney- related research conducted at UT Southwestern, the North Texas region, nationally, and internationally. The research base consists of 41 externally funded investigators who are conducting basic research in the areas of kidney physiology & cell biology, injury & inflammation, developmental biology & molecular genetics, and renal cystic diseases. Clinical/translational research is conducted in the areas of acute & chronic kidney disease, kidney & cardiovascular disease, and electrolyte & mineral metabolism. The Center will be located in 15,000 sq ft of newly renovated space in the nephrology division and will utilize existing core facilities in human genetics, transgenic technologies, and molecular pathology. The Pilot & Feasibility Program will support two grants per year for investigators who are new to the field. The Educational Enrichment Program will include a research seminar, annual symposium, training grants, and courses offered by a new Dept. of Clinical Sciences. By strengthening existing collaborations and attracting outside investigators, the Center will promote new multidisciplinary approaches to understanding the causes and treatment of renal diseases.
总体描述(由申请人提供):
这是在达拉斯德克萨斯大学西南医学中心建立乔治·M·奥布莱恩肾脏研究核心中心的新申请。主任是内科和儿科教授兼肾内科主任 Peter Igarashi 博士。该中心的总体目标是促进基础科学家和临床研究人员之间的双向互动,以增强我们对肾脏发育和病理生理学的理解,并更有效地治疗肾脏疾病及其并发症。这一目标将通过创建新的肾脏疾病动物模型和开发核心设施来实现,这些设施将使正在进行基础研究的医生科学家能够更轻松地将他们的发现转化为人类。相反,研究肾病患者的临床研究人员将识别分子和遗传异常,然后对其进行研究,以获得对疾病发病机制和治疗的新见解。为了实现这些目标,该中心将支持五个生物医学研究核心、一个试点和可行性计划以及一个教育丰富计划。生物医学研究核心是:1) 动物模型,2) 生理学,3) 细胞生物学和病理学,4) 分子遗传学,5) 临床/转化。该核心将支持德克萨斯大学西南分校、北德克萨斯地区、国内和国际正在进行的肾脏相关研究。该研究基地由41名外部资助的研究人员组成,主要从事肾脏生理学与细胞生物学、损伤与炎症、发育生物学与分子遗传学、肾囊性疾病等领域的基础研究。临床/转化研究在急性和慢性肾脏疾病、肾脏和心血管疾病以及电解质和矿物质代谢领域进行。该中心将坐落于肾脏科新装修的 15,000 平方英尺空间内,并将利用人类遗传学、转基因技术和分子病理学方面的现有核心设施。试点和可行性计划每年将为新进入该领域的研究人员提供两笔资助。教育丰富计划将包括研究研讨会、年度研讨会、培训补助金以及新的临床科学系提供的课程。通过加强现有合作并吸引外部研究人员,该中心将推广新的多学科方法来了解肾脏疾病的原因和治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Peter Igarashi其他文献
Peter Igarashi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Peter Igarashi', 18)}}的其他基金
MicroRNA-Based Therapeutics for Rare Cystic Kidney Diseases
基于 MicroRNA 的罕见囊性肾病治疗方法
- 批准号:
7936337 - 财政年份:2009
- 资助金额:
$ 1.9万 - 项目类别:
MicroRNA-Based Therapeutics for Rare Cystic Kidney Diseases
基于 MicroRNA 的罕见囊性肾病治疗方法
- 批准号:
7832043 - 财政年份:2009
- 资助金额:
$ 1.9万 - 项目类别:
UT Southwestern O'Brien Kidney Research Core Center
德州大学西南奥布莱恩肾脏研究核心中心
- 批准号:
7883980 - 财政年份:2009
- 资助金额:
$ 1.9万 - 项目类别:
MicroRNA-Based Therapeutics for Rare Cystic Kidney Diseases
基于 MicroRNA 的罕见囊性肾病治疗方法
- 批准号:
7936337 - 财政年份:2009
- 资助金额:
$ 1.9万 - 项目类别:
UT Southwestern O'Brien Kidney Research Core Center
德州大学西南奥布莱恩肾脏研究核心中心
- 批准号:
7325171 - 财政年份:2007
- 资助金额:
$ 1.9万 - 项目类别:
UT southwestern O'Brien Kidney Research Core Center
德克萨斯大学西南奥布莱恩肾脏研究核心中心
- 批准号:
8912182 - 财政年份:2007
- 资助金额:
$ 1.9万 - 项目类别:
相似国自然基金
髋关节撞击综合征过度运动及机械刺激动物模型建立与相关致病机制研究
- 批准号:82372496
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
探索在急性呼吸窘迫综合征动物模型和患者长时间俯卧位通气过程中动态滴定呼气末正压的意义
- 批准号:82270081
- 批准年份:2022
- 资助金额:76 万元
- 项目类别:面上项目
雌激素抑制髓系白血病动物模型中粒细胞异常增生的机制
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于中医经典名方干预效应差异的非酒精性脂肪性肝病动物模型证候判别研究
- 批准号:
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
无菌动物模型与单细胞拉曼技术结合的猴与人自闭症靶标菌筛选及其机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Prototype development and validation of soft robotic sensor arrays for mapping cardiac arrhythmia
用于绘制心律失常的软机器人传感器阵列的原型开发和验证
- 批准号:
10722857 - 财政年份:2023
- 资助金额:
$ 1.9万 - 项目类别:
The protective role of kidney-derived Tamm Horsfall protein (Uromodulin) in sepsis
肾源性 Tamm Horsfall 蛋白(尿调节蛋白)在脓毒症中的保护作用
- 批准号:
10886979 - 财政年份:2023
- 资助金额:
$ 1.9万 - 项目类别:
Neural pathways for obesity development by AgRP neurons
AgRP 神经元导致肥胖发展的神经通路
- 批准号:
10681993 - 财政年份:2023
- 资助金额:
$ 1.9万 - 项目类别:
Mentoring in cholinergic regulation of vascular oxidation
血管氧化的胆碱能调节的指导
- 批准号:
10664768 - 财政年份:2023
- 资助金额:
$ 1.9万 - 项目类别:
Optogenetic and chemogenetic regulation of uterine vascular function
子宫血管功能的光遗传学和化学遗传学调控
- 批准号:
10785667 - 财政年份:2023
- 资助金额:
$ 1.9万 - 项目类别: